Summary of Purpose
The purpose of this study is to investigate the Safety and Efficacy of Cilostazol in slowing down the progression of peripheral arterial disease (PAD) in ischemic stroke patients with PAD in Taiwan.Read More →
The following dates are available for this trial. Trial information last updated on 30 September 2013.
|1 Sep 2010||23 Aug 2010||1 Jul 2013||1 Jul 2013||1 Jul 2013||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Sponsors See All
- Allocation: Randomized
- Masking: Double Blind (Subject, Investigator)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Chung Y. Hsu, MD. Ph.D.